Period | Screening | Â | Treatment | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Week | Â | PB | B | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
Daily 0–10 pain diary | X |  |  | X | X | X | X | X | X | X | X |
Presence of endometriosis comorbidities | X | Â | Â | X | X | X | X | X | X | X | X |
Rescue analgesic medication usage | X | Â | Â | X | X | X | X | X | X | X | X |
Proof of laparoscopic diagnosis | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Eligibility screening | X | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Informed consent signed | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Randomisation | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Demographic characteristics | Â | X | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ENDOCOST Survey | Â | Â | Xa | Â | Â | Â | Â | Â | Â | Â | Â |
EHP-30 | Â | Â | Xa | Â | Â | Â | Â | Â | Â | Â | X |
Internal Health Locus of Control measurement | Â | Â | Xa | Â | Â | Â | Â | Â | Â | Â | X |
EXPECT questionnaire | Â | Â | Xa | Â | Â | Â | Â | Â | Â | Â | Â |
CPM | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Xb |
IL-6 levels | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Xb |
EEG | Â | Â | X | Â | Â | Â | Â | Â | Â | Â | Xb |
Acupuncture treatment | Â | Â | Â | X | X | X | X | X | X | X | X |
Safety assessment | Â | Â | Â | X | X | X | X | X | X | X | X |
CGI-I | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |
Treatment satisfaction/feasibility measures | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | X |